GP
LKFT

Girard Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Girard Partners’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-175
Closed -$19K – 450
2018
Q3 		$19K Buy
+175
New +$18.5K ﹤0.01% 609

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Girard Partners's LKFT Position: Q4 2018 in Review

Girard Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018, closing a stake of 175 shares — an estimated $19K sold.

Girard Partners first reported a position in LKFT in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.

  • Girard Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 175 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2018, an estimated $19K.
  • Girard Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • Girard Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $19K in Q3 2018.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.